- Home
- Personal stories
Personal stories
Inside the development of a revolutionary treatment for blood cancers
In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
“Lung cancer wasn’t even on my radar. Then I was diagnosed.”
The disease is often detected late—which can have fatal consequences. But thanks to innovations in diagnostic tools, there’s a way to catch lung cancer earlier. Here’s how early detection saved one woman’s life.
“I’m a scientist dedicated to bringing eye-health innovations to the world”
Meet Xiao-Yu Song, Global Head of Research & Development for Vision at Johnson & Johnson, who leads a talented team that creates cutting-edge products addressing vision problems through all stages of life.
Meet a nurse who leads clinical trials to find innovative cancer therapies
Melissa Martinez is a clinical scientist within Johnson & Johnson’s Interventional Oncology R&D group. Not only is she helping to develop lifesaving treatments, she’s redefining what it means to pursue a career in nursing.
In Front of Cancer: Mary’s Story
Each day, we are working toward our ambition to get in front of cancer.
How robots are helping personalize knee replacement surgery
Learn the latest about this common procedure and how Johnson & Johnson MedTech is innovating to improve patient outcomes.
“I couldn’t speak, walk or sit.” Inside dermatomyositis, a rare autoimmune disease that attacks the muscles
Elisa Glass was diagnosed with dermatomyositis, which causes severe muscle weakness throughout the body. Learn more about the disease and how Johnson & Johnson is working to develop a treatment to help Glass and other patients like her.
5 things we now know about bladder cancer
Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. Learn how Johnson & Johnson is helping to change the treatment landscape.
What is IL-23?
This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.